SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense discussion and trending upwards, fueled by reports of substantial institutional buying and notable options activity. The community is bullish, highlighting strong technical indicators and increasing volume as signs of an impending breakout. This surge in interest is also attributed to a broader positive shift in housing market sentiment and a rotation into small-cap technology stocks.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW, or Crow with Knife, is trending due to its prominent multi-chain presence, actively bridging across networks like Solana, Cronos, and Ethereum via Layerzero technology. The community is generating significant buzz around its fully decentralized, organic growth, and deflationary burn mechanism, positioning it as a compelling contender within the meme coin sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is actively trending due to renewed geopolitical focus on Greenland's strategic rare earth deposits, highlighted by U.S. administration comments and the appointment of a special envoy. The community is widely discussing the potential for government investment or partnership in CRML's Tanbreez project, viewing it as vital for Western supply chain independence and eagerly anticipating upcoming feasibility study results.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is generating significant buzz following its recent substantial debt reduction and the strategic acquisition of Ask Sage, firmly positioning the company in secure generative AI for defense and government sectors. The community is actively discussing the imminent potential for major government contract wins, often drawing comparisons to early Palantir, despite some persistent chatter about potential share dilution. Many investors foresee a breakout into double-digit prices, driven by its strengthened financial position and perceived critical role in national security applications.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending amidst sharp market volatility, primarily driven by recent downgrades from major financial institutions, which many in the community perceive as a manipulative tactic by competitors to acquire shares at a discount. This intense trading activity is prompting discussions of a strategic buying opportunity for long-term holders, anticipating strong upcoming earnings and potential S&P 500 inclusion, despite frustration over what's seen as repeated institutional tactics.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending following its inclusion in the S&P MidCap 400, which has generated significant investor buzz around anticipated institutional buying and increased liquidity. The community is highly optimistic, discussing the company's pivotal role in agentic AI orchestration and its potential for substantial growth as enterprises accelerate autonomous automation adoption.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending amid an intense rally in memory and storage stocks, driven by soaring demand from AI infrastructure buildouts and rising prices for essential components. The community is actively debating if its rapid appreciation reflects a legitimate "memory supercycle" or an "overpriced bubble," with many expressing FOMO while others anticipate a pullback. This strong movement is widely seen as a reflection of the broader sector's response to unprecedented AI-driven data center needs.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is experiencing significant investor interest driven by anticipation of an upcoming Congressional hearing on nuclear energy and a crucial DOE announcement regarding surplus plutonium allocation. The community is actively discussing the potential for a short squeeze and institutional accumulation, viewing these catalysts as pivotal for the company's role in powering AI data centers and advancing the 'new nuclear era'.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings is trending due to an exceptionally high cost to borrow and limited short-share availability, igniting strong community speculation around a potential short and gamma squeeze. Traders are keenly watching key price levels as the stock exhibits high volatility, drawing comparisons to its past parabolic movements and other significant meme stock runs. Despite underlying fundamental questions, the current market conversation centers on the technical setup and the expectation of a sustained upside move.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis is trending following the announcement of highly positive Phase 3 clinical trial results for its oral TYK2 inhibitor in moderate-to-severe plaque psoriasis, showcasing strong skin clearance and a favorable safety profile. While many celebrate the drug's "best in class" potential, the community is actively debating the likelihood of an imminent stock offering that could impact short-term valuation and create volatility amidst heavy trading action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Morgan Stanley

Morgan Stanley assumed coverage on BridgeBio Pharma in a research report on Tuesday. They issued an "overweight" rating and a $96.00 target price for the company...

BridgeBio Pharma (NASDAQ:BBIO) Stock Price Down 6.5% - Should You Sell?

BridgeBio Pharma (NASDAQ:BBIO) Trading Down 6.5% - Should You Sell...

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's What Happened

BridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Should You Buy...

Moody Aldrich Partners LLC Has $3.72 Million Stake in BridgeBio Pharma, Inc. $BBIO

Moody Aldrich Partners LLC decreased its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 25.0% in the 3rd quarter, according to the company in its most recent 13F filing with the...

Corient Private Wealth LLC Acquires New Holdings in BridgeBio Pharma, Inc. $BBIO

Corient Private Wealth LLC purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the...

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week High - Here's What Happened...

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-two ratings firms that are presently covering the stock...

Assenagon Asset Management S.A. Trims Stake in BridgeBio Pharma, Inc. $BBIO

Assenagon Asset Management S.A. decreased its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 26.1% in the 3rd quarter, according to its most recent Form 13F filing with...

Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 30,011 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 30,011 shares of the business's stock in a transaction dated Monday, December 15th. The stock was sold at an average price...

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 30,011 shares of BridgeBio Pharma stock in a transaction dated Monday, December 15th. The stock was sold at an average price...

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Current Price	$72.60
Prev Close	$73.42
Open	$73.79
Dividend Yield	0.00%
50-Day Moving Average	$69.52
Beta	1.32
Avg. Volume	1.79M
PE Ratio	-17.54

52-Week High	$78.59
52-Week Low	$28.10
Market Capitalization	$14.6B
EPS (Annual)	-$2.88
Price to Book	-7.32
Revenue Per Employee	$303,975.34
Enterprise Value/EBITDA	N/A

BBIO
BridgeBio Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBIO News

BBIOBridgeBio Pharma Inc